Atossa Therapeutics (Germany) Market Value
| YAG2 Stock | 1.20 0.01 0.83% |
| Symbol | Atossa |
Atossa Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Atossa Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Atossa Therapeutics.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Atossa Therapeutics on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Atossa Therapeutics or generate 0.0% return on investment in Atossa Therapeutics over 30 days. Atossa Therapeutics is related to or competes with QUEEN S, Uber Technologies, Gold Road, Amkor Technology, RCM TECHNOLOGIES, AAC TECHNOLOGHLDGADR, and KAUFMAN ET. More
Atossa Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Atossa Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Atossa Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.31 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 17.95 | |||
| Value At Risk | (4.58) | |||
| Potential Upside | 6.35 |
Atossa Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atossa Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Atossa Therapeutics' standard deviation. In reality, there are many statistical measures that can use Atossa Therapeutics historical prices to predict the future Atossa Therapeutics' volatility.| Risk Adjusted Performance | 0.014 | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.53) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0201 |
Atossa Therapeutics Backtested Returns
Currently, Atossa Therapeutics is dangerous. Atossa Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0083, which signifies that the company had a 0.0083% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Atossa Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Atossa Therapeutics' Mean Deviation of 2.18, risk adjusted performance of 0.014, and Downside Deviation of 3.31 to double-check if the risk estimate we provide is consistent with the expected return of 0.0272%. The firm shows a Beta (market volatility) of 0.85, which signifies possible diversification benefits within a given portfolio. Atossa Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Atossa Therapeutics is expected to follow. Atossa Therapeutics right now shows a risk of 3.27%. Please confirm Atossa Therapeutics maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Atossa Therapeutics will be following its price patterns.
Auto-correlation | 0.16 |
Very weak predictability
Atossa Therapeutics has very weak predictability. Overlapping area represents the amount of predictability between Atossa Therapeutics time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Atossa Therapeutics price movement. The serial correlation of 0.16 indicates that over 16.0% of current Atossa Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.16 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Atossa Therapeutics lagged returns against current returns
Autocorrelation, which is Atossa Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Atossa Therapeutics' stock expected returns. We can calculate the autocorrelation of Atossa Therapeutics returns to help us make a trade decision. For example, suppose you find that Atossa Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Atossa Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Atossa Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Atossa Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Atossa Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Atossa Therapeutics Lagged Returns
When evaluating Atossa Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Atossa Therapeutics stock have on its future price. Atossa Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Atossa Therapeutics autocorrelation shows the relationship between Atossa Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Atossa Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Therapeutics' price analysis, check to measure Atossa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Therapeutics is operating at the current time. Most of Atossa Therapeutics' value examination focuses on studying past and present price action to predict the probability of Atossa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Therapeutics' price. Additionally, you may evaluate how the addition of Atossa Therapeutics to your portfolios can decrease your overall portfolio volatility.